Home » Stocks » OMCL

Omnicell, Inc. (OMCL)

Stock Price: $107.09 USD 2.17 (2.07%)
Updated November 23, 2:41 PM EST - Market open

Stock Price Chart

Key Info

Market Cap 4.53B
Revenue (ttm) 891.30M
Net Income (ttm) 37.91M
Shares Out 42.31M
EPS (ttm) 0.87
PE Ratio 123.09
Forward PE 31.45
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 23
Last Price $107.09
Previous Close $104.92
Change ($) 2.17
Change (%) 2.07%
Day's Open 106.00
Day's Range 104.66 - 107.56
Day's Volume 334,077
52-Week Range 54.24 - 107.56

More Stats

Market Cap 4.53B
Enterprise Value 4.41B
Earnings Date (est) Feb 11, 2021
Ex-Dividend Date n/a
Shares Outstanding 42.31M
Float 41.54M
EPS (basic) 0.91
EPS (diluted) 0.87
FCF / Share 2.01
Dividend n/a
Dividend Yield n/a
Earnings Yield 0.81%
FCF Yield 1.90%
Payout Ratio n/a
Shares Short 2.99M
Short Ratio 5.57
Short % of Float 7.21%
Beta 0.92
PE Ratio 123.09
Forward PE 31.45
P/FCF Ratio 52.58
PS Ratio 5.08
PB Ratio 4.70
Revenue 891.30M
Operating Income 37.49M
Net Income 37.91M
Free Cash Flow 86.17M
Net Cash 122.69M
Net Cash / Share 2.90
Gross Margin 49.02%
Operating Margin 4.21%
Profit Margin 4.30%
FCF Margin 9.67%
ROA 2.00%
ROE 4.39%
ROIC 6.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (8)

Buy 5
Overweight 0
Hold 3
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$93.25*
(-12.92% downside)
Low
80.0
Current: $107.09
High
105.0
Target: 93.25
*Average 12-month price target from 8 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue897787713696485441381314246222
Revenue Growth13.94%10.47%2.41%43.62%9.9%15.85%21.19%27.9%10.4%-
Gross Profit437372319317248234203171136118
Operating Income78.3544.3911.1521.4145.1949.5835.3027.1316.229.53
Net Income61.3437.7330.529.7630.7630.5223.9816.1810.394.89
Shares Outstanding41.4639.2437.4836.1635.8635.6534.7433.3133.1232.65
Earnings Per Share1.430.930.790.260.840.830.670.470.300.15
EPS Growth53.76%17.72%203.85%-69.05%1.2%23.88%42.55%56.67%100%-
Operating Cash Flow14510424.8349.9038.4965.1655.2639.4831.2420.60
Capital Expenditures-61.66-54.37-30.38-27.79-19.67-22.28-20.10-20.15-12.88-9.10
Free Cash Flow83.3449.59-5.5522.1118.8142.8935.1719.3418.3711.50
Cash & Equivalents12767.1932.4254.4982.2212610562.31200184
Total Debt101135210254------
Net Cash / Debt26.54-68.23-178-20082.2212610562.31200184
Assets1,2411,0811,016935579560493442364343
Liabilities39640246250317617014413480.9478.01
Book Value845680554432402390349308283265
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Omnicell, Inc.
Country United States
Employees 2,670
CEO Randall A. Lipps

Stock Information

Ticker Symbol OMCL
Stock Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Unique Identifier NASDAQ: OMCL
IPO Date August 7, 2001

Description

Omnicell, together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies worldwide. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; Omnicell Interface Software that offers interface and integration between its medication-use products or supply products, and a healthcare facility's in-house information management systems; and robotic dispensing systems used in hospitals and retail pharmacies for handling the stocking and retrieval of boxed medications. In addition, the company provides single dose automation solutions to fill and label for incoming prescriptions; medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings; automated systems to help pharmacies in filling its multimed adherence packaging based on individual patient medication orders; and semi-automated filling equipment for the long-term care institutional pharmacy. Further, it offers Omnicell Patient Engagement, a web-based nexus of solutions; and patient communication tools, such as interactive voice response, outbound communications, and mobile app. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was founded in 1992 and is headquartered in Mountain View, California.